LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 7.01 | 17.25 | 876 | 389 | 2.2490 | 1.3950 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 8.98 | 17.25 | 9 | 445 | 0.0202 | -0.1296 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 8.98 | 17.25 | 839 | 445 | 1.8851 | 1.2895 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 8.98 | 17.25 | 1066 | 445 | 2.3951 | 1.4095 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 10.95 | 17.25 | 14 | 471 | 0.0297 | -0.0428 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 10.95 | 17.25 | 892 | 471 | 1.8915 | 1.2858 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 10.95 | 17.25 | 1145 | 471 | 2.4281 | 1.4085 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 12.91 | 17.25 | 7 | 494 | 0.0141 | -0.1700 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 12.91 | 17.25 | 938 | 494 | 1.8955 | 1.2824 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 12.91 | 17.25 | 1201 | 494 | 2.4270 | 1.4019 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.88 | 17.25 | 6 | 534 | 0.0112 | -0.1920 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.88 | 17.25 | 979 | 534 | 1.8319 | 1.2600 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.88 | 17.25 | 1277 | 534 | 2.3895 | 1.3845 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.85 | 17.25 | 11 | 655 | 0.0168 | -0.0822 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.85 | 17.25 | 1101 | 655 | 1.6795 | 1.2077 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 16.85 | 17.25 | 1447 | 655 | 2.2072 | 1.3257 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.82 | 17.25 | 7 | 800 | 0.0087 | -0.1504 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.82 | 17.25 | 1218 | 800 | 1.5215 | 1.1575 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | I17 |